Announcements
Projects
Orgs
Project
Articles 48
Votes 0
Gavi.org
Nearly half of COVID-19 survivors in Africa experiencing Long COVID symptoms, study suggests - Gavi, the Vaccine Alliance
~2y
More than US$ 1.8 billion in support for African vaccine manufacturing, catching up missed children and pandemic preparedness approved as Gavi Board steps up efforts to tackle backsliding and fight health emergencies - Gavi, the Vaccine Alliance
~2y
Health workers: key to the success of the Malaria Vaccine Implementation Programme - Gavi, the Vaccine Alliance
~2y
Antibiotic Shortages Are Fueling Antimicrobial Resistance - Gavi, the Vaccine Alliance
~2y
Childhood pneumonia deaths “greatly reduced” in Kenya following PCV vaccination - Gavi, the Vaccine Alliance
~2y
RTS,S vaccine pilot: 13% mortality reduction fuels hope for malaria control - Gavi, the Vaccine Alliance
~2y
Bird flu could be eradicated by editing the genes of chickens - our study shows how - Gavi, the Vaccine Alliance
~2y
Paper jam: Ugandan vaccinators ditch old school ledgers and trial digital alternatives - Gavi, the Vaccine Alliance
~2y
Why we need integrated dengue management to achieve zero deaths - Gavi, the Vaccine Alliance
~2y
Vaccines could prevent half a million deaths linked with drug resistance a year - Gavi, the Vaccine Alliance
>2y
Long COVID: brain function still affected for some up to two years after infection – new research - Gavi, the Vaccine Alliance
>2y
Q&A: How “vaccine libraries” could arm us against the next pandemic - Gavi, the Vaccine Alliance
>2y
Hope spreads as 18 million doses of the first malaria vaccine are allocated to 12 African countries - Gavi, the Vaccine Alliance
>2y
18 million doses of first-ever malaria vaccine allocated to 12 African countries for 2023–2025: Gavi, WHO and UNICEF - Gavi, the Vaccine Alliance
>2y
New hexavalent vaccines are coming: What impact could they have? - Gavi, the Vaccine Alliance
>2y
Global Vaccine Alliance to deploy six-in-one vaccine to lower-income countries, establish innovative mechanisms to protect against future epidemic threats - Gavi, the Vaccine Alliance
>2y
David Marlow to Become Interim Chief Executive Officer of Gavi - Gavi, the Vaccine Alliance
>2y
“Promising” trial results suggest chikungunya vaccine could be within reach - Gavi, the Vaccine Alliance
>2y
Sewer robots identify and destroy dengue dens - Gavi, the Vaccine Alliance
>2y
Vaccine trial boosts hope of eliminating meningococcal disease in sub-Saharan Africa - Gavi, the Vaccine Alliance
>2y
Genomic study may help fight severe dengue disease - Gavi, the Vaccine Alliance
>2y
The Big Catch Up: Recovering the Gains Made in Africa through Vaccinations - Gavi, the Vaccine Alliance
>2y
Three countries that have seen the impact of COVID-19 vaccine delivery funding - Gavi, the Vaccine Alliance
>2y
Could the “Arcturus” variant trigger a new wave of COVID-19 infections and deaths? - Gavi, the Vaccine Alliance
>2y
Down – not out: COVID-19 cases surge in India - Gavi, the Vaccine Alliance
>2y